Leukemia, the blood cancer, is a group of hematopoietic malignancies. Many types of leukemia are associated with poor outcome. Unfortunately, during the past few decades, the first-line leukemia therapy has long been traditional ...
Feb 22, 2022
0
5
Some genetic mutations linked to leukemia are less than useful guides to making treatment decisions for patients. A new study from the University of Wisconsin–Madison suggests a group of clinical signs that can be paired ...
Feb 22, 2022
0
70
A woman with HIV who received a cord blood stem cell transplant to treat acute myeloid leukemia has had no detectable levels of HIV for 14 months despite cessation of antiretroviral therapy (ART), according to a presentation ...
Feb 15, 2022
0
5
Researchers have developed a new protocol for monitoring acute lymphoblastic leukemia (ALL), the most common cancer in children, to inform more effective treatment strategies and detect disease recurrence. The personalized ...
Feb 8, 2022
0
6
Scientists at St. Jude Children's Research Hospital and the Cancer Research Center in Spain blocked development of acute lymphoblastic leukemia in mice with a genetic mutation that increases the risk of childhood cancer.
Feb 7, 2022
0
7
Scientists at St. Jude Children's Research Hospital have revealed a biological mechanism that increases the odds of developing a high-risk type of pediatric leukemia. Inherited (germline) genetic variants have been associated ...
Feb 3, 2022
0
24
(HealthDay)—A polygenic score derived from pharmacogenomic evaluation of cytarabine (ara-C) pathway can help personalize treatment for pediatric patients with acute myeloid leukemia (AML), according to a study published ...
Feb 1, 2022
0
5
(HealthDay)—Night shift work may increase the risk for chronic lymphocytic leukemia (CLL), according to a study published online Jan. 13 in Occupational & Environmental Medicine.
Jan 25, 2022
0
0
(HealthDay)—A composite score can identify patients with chronic lymphocytic leukemia (CLL) with very low risk for requiring treatment, according to a study published online Jan. 14 in the European Journal of Haematology.
Jan 25, 2022
0
1
For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic stem cell transplantation (HCT), the two-year overall survival rate has nearly ...
Jan 12, 2022
0
8
